2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
9
Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Multiple Myeloma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Rectal Neoplasms
2
Radiation Injuries
2
Prostatic Neoplasms
2
Preleukemia
2
Precancerous Conditions
2
Osteosarcoma
2
Neoplasms by Histologic Type
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Multiple Chronic Conditions
2
Melanoma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Lung Neoplasms
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Leukemia, Biphenotypic, Acute
2
Interventions
Oxaliplatin
11
Mitomycin
11
Leucovorin
7
Hyperthermic Intraperitoneal Chemotherapy
7
Irinotecan
6
Fluorouracil
6
Cisplatin
4
Capecitabine
4
Surveys and Questionnaires
3
Doxorubicin
3
Cytoreduction Surgical Procedures
3
dehydroftorafur
2
Trastuzumab
2
Thalidomide
2
Mitozytrex
2
Melphalan
2
Interleukin-12 Subunit p35
2
Floxuridine
2
Drug Therapy
2
Cetuximab
2
Biopsy
2
tipifarnib
1
surufatinib
1
sodium thiosulfate
1
sintilimab
1
nintedanib
1
nilotinib
1
motexafin lutetium
1
irinotecan sucrosofate
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Appendiceal Neoplasms
×
Patient Reported Outcome Measures
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled